Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOSPEL: Goal Oriented Strategy to Preserve Ejection Fraction in PAH
NCT03236818Phase 4Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2013
- Primary completion
- Sep 2017
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sildenafil, tadalafil, bosentan, macitentan in pulmonary arterial hypertension (PAH), sponsored by Amsterdam University Medical Center. Status: unknown.
02
Drugs
sildenafiltadalafilbosentanmacitentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03236818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236818.